Design Therapeutics, Inc. - stock earnings
DSGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -15.8 million USD | ? USD |
| 2023Q2 | -19.9 million USD | ? USD |
| 2023Q1 | -16.9 million USD | ? USD |
| 2022Q4 | -15.2 million USD | ? USD |
| 2022Q3 | -16.2 million USD | ? USD |
| 2022Q2 | -14.4 million USD | ? USD |
| 2022Q1 | -13.2 million USD | ? USD |
| 2021Q4 | -11.1 million USD | ? USD |
| 2021Q3 | -11.3 million USD | ? USD |
| 2021Q2 | -7.6 million USD | ? USD |
| 2021Q1 | -5.5 million USD | ? USD |
| 2020Q4 | -3.9 million USD | ? USD |
| 2020Q3 | -2.3 million USD | 20000 USD |
| 2020Q2 | -1.4 million USD | 31000 USD |
| 2020Q1 | -663000 USD | 142000 USD |
DSGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.4 million USD | ? USD |
| 2022 | -58.6 million USD | ? USD |
| 2021 | -35.5 million USD | ? USD |
| 2020 | -8.3 million USD | 226 USD |
| 2019 | -2.0 million USD | 834000 USD |
DSGN
Price: $4.41
52 week price:
Earnings Per Share: -1.16 USD
P/E Ratio: -1.78
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 301800
Market Capitalization: 213.0 million